Work

Lilly to pour $6.5 billion into GLP-1 pill manufacturing

Year: 2025

Type: other

Source: C&EN Global Enterprise

DOI: 10.1021/cen-10321-buscon3

Author: Aayushi Pratap

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7092645249

Cites:

Cited by:

Related to: